These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 32775464)

  • 1. Neurocognitive Function, Psychosocial Outcome, and Health-Related Quality of Life of the First-Generation Metastatic Melanoma Survivors Treated with Ipilimumab.
    Rogiers A; Leys C; Lauwyck J; Schembri A; Awada G; Schwarze JK; De Cremer J; Theuns P; Maruff P; De Ridder M; Bernheim JL; Neyns B
    J Immunol Res; 2020; 2020():2192480. PubMed ID: 32775464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life, emotional burden, and neurocognitive function in the first generation of metastatic melanoma survivors treated with pembrolizumab: a longitudinal pilot study.
    Rogiers A; Leys C; De Cremer J; Awada G; Schembri A; Theuns P; De Ridder M; Neyns B
    Support Care Cancer; 2020 Jul; 28(7):3267-3278. PubMed ID: 31745697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression, anxiety and quality of life in long-term survivors of malignant melanoma: a register-based cohort study.
    Beutel ME; Fischbeck S; Binder H; Blettner M; Brähler E; Emrich K; Friedrich-Mai P; Imruck BH; Weyer V; Zeissig SR
    PLoS One; 2015; 10(1):e0116440. PubMed ID: 25615573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life with adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): secondary outcomes of a multinational, randomised, double-blind, phase 3 trial.
    Coens C; Suciu S; Chiarion-Sileni V; Grob JJ; Dummer R; Wolchok JD; Schmidt H; Hamid O; Robert C; Ascierto PA; Richards JM; Lebbé C; Ferraresi V; Smylie M; Weber JS; Maio M; Bottomley A; Kotapati S; de Pril V; Testori A; Eggermont AMM
    Lancet Oncol; 2017 Mar; 18(3):393-403. PubMed ID: 28162999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life and neurocognitive functioning in patients with recurrent glioblastoma treated with intracerebral immune checkpoint inhibition.
    Geens W; Vanlaer N; Nijland L; Van Laere S; Schwarze JK; Bruneau M; Neyns B; Rogiers A; Duerinck J
    J Neurooncol; 2024 May; 168(1):159-169. PubMed ID: 38502281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life and psychological distress among cancer survivors in Southeast Asia: results from a longitudinal study in eight low- and middle-income countries.
    ACTION Study Group
    BMC Med; 2017 Jan; 15(1):10. PubMed ID: 28081724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life in long-term survivors of advanced melanoma treated with checkpoint inhibitors.
    Mamoor M; Postow MA; Lavery JA; Baxi SS; Khan N; Mao JJ; Rogak LJ; Sidlow R; Thom B; Wolchok JA; Korenstein D
    J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32152222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Quality of Life in Adult Survivors of Pediatric Differentiated Thyroid Carcinoma.
    Nies M; Klein Hesselink MS; Huizinga GA; Sulkers E; Brouwers AH; Burgerhof JGM; van Dam EWCM; Havekes B; van den Heuvel-Eibrink MM; Corssmit EPM; Kremer LCM; Netea-Maier RT; van der Pal HJH; Peeters RP; Plukker JTM; Ronckers CM; van Santen HM; Tissing WJE; Links TP; Bocca G
    J Clin Endocrinol Metab; 2017 Apr; 102(4):1218-1226. PubMed ID: 28001468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does fear of cancer recurrence differ between cancer types? A study from the population-based PROFILES registry.
    van de Wal M; van de Poll-Franse L; Prins J; Gielissen M
    Psychooncology; 2016 Jul; 25(7):772-8. PubMed ID: 26464337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life and psychological distress among cancer survivors in a middle-income country.
    Subramaniam S; Kong YC; Chinna K; Kimman M; Ho YZ; Saat N; Malik RA; Taib NA; Abdullah MM; Lim GC; Tamin NI; Woo YL; Chang KM; Goh PP; Yip CH; Bhoo-Pathy N
    Psychooncology; 2018 Sep; 27(9):2172-2179. PubMed ID: 29856903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychosocial Care Needs of Melanoma Survivors: Are They Being Met?
    Fischbeck S; Imruck BH; Blettner M; Weyer V; Binder H; Zeissig SR; Emrich K; Friedrich-Mai P; Beutel ME
    PLoS One; 2015; 10(8):e0132754. PubMed ID: 26296089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life and psychological well-being of breast cancer survivors in Jordan.
    Abu-Helalah M; Al-Hanaqta M; Alshraideh H; Abdulbaqi N; Hijazeen J
    Asian Pac J Cancer Prev; 2014; 15(14):5927-36. PubMed ID: 25081724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The health-related quality of life of long-term survivors of melanoma treated with isolated limb perfusion.
    Noorda EM; van Kreij RH; Vrouenraets BC; Nieweg OE; Muller M; Kroon BB; Aaronson NK
    Eur J Surg Oncol; 2007 Aug; 33(6):776-82. PubMed ID: 17300914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low subjective health literacy is associated with adverse health behaviors and worse health-related quality of life among colorectal cancer survivors: results from the profiles registry.
    Husson O; Mols F; Fransen MP; van de Poll-Franse LV; Ezendam NP
    Psychooncology; 2015 Apr; 24(4):478-86. PubMed ID: 25241852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related quality of life of long-term advanced melanoma survivors treated with anti-CTLA-4 immune checkpoint inhibition compared to matched controls.
    Boekhout AH; Rogiers A; Jozwiak K; Boers-Sonderen MJ; van den Eertwegh AJ; Hospers GA; de Groot JWB; Aarts MJB; Kapiteijn E; Ten Tije AJ; Piersma D; Vreugdenhil G; van der Veldt AA; Suijkerbuijk KPM; Rozeman EA; Neyns B; Janssen KJ; van de Poll-Franse LV; Blank CU
    Acta Oncol; 2021 Jan; 60(1):69-77. PubMed ID: 32924708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatigue among short- and long-term thyroid cancer survivors: results from the population-based PROFILES registry.
    Husson O; Nieuwlaat WA; Oranje WA; Haak HR; van de Poll-Franse LV; Mols F
    Thyroid; 2013 Oct; 23(10):1247-55. PubMed ID: 23578315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subjective cognitive functioning and associations with psychological distress in adult brain tumour survivors.
    Nicol C; Ownsworth T; Cubis L; Nguyen W; Foote M; Pinkham MB
    J Cancer Surviv; 2019 Oct; 13(5):653-662. PubMed ID: 31313128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitors.
    O'Reilly A; Hughes P; Mann J; Lai Z; Teh JJ; Mclean E; Edmonds K; Lingard K; Chauhan D; Lynch J; Au L; Ludlow A; Pattison N; Wiseman T; Turajlic S; Gore M; Larkin J; Husson O
    Support Care Cancer; 2020 Feb; 28(2):561-570. PubMed ID: 31089820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of fatigue, depression, and anxiety as factors affecting posttreatment health-related quality of life in lung cancer survivors.
    Jung JY; Lee JM; Kim MS; Shim YM; Zo JI; Yun YH
    Psychooncology; 2018 Feb; 27(2):465-470. PubMed ID: 28755492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interpreting European Organisation for Research and Treatment for Cancer Quality of life Questionnaire core 30 scores as minimally importantly different for patients with malignant melanoma.
    Musoro JZ; Bottomley A; Coens C; Eggermont AM; King MT; Cocks K; Sprangers MA; Groenvold M; Velikova G; Flechtner HH; Brandberg Y;
    Eur J Cancer; 2018 Nov; 104():169-181. PubMed ID: 30359910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.